Is computed tomography assessment of residual arterial pedicle length following colorectal cancer surgery a useful marker of surgical quality? - Takeaways - MDSpire

Is computed tomography assessment of residual arterial pedicle length following colorectal cancer surgery a useful marker of surgical quality?

  • By

  • K. Naidu

  • P. Chapuis

  • J. Yang

  • S. Koneru

  • C. Chan

  • M. Rickard

  • K.-S. Ng

  • April 12, 2025

  • 0 min

Share

  • 1

    The study investigates the feasibility of measuring residual arterial pedicle length (RAPL) using CT imaging after colorectal cancer surgery.

  • 2

    RAPL measurement aims to serve as a marker for surgical quality, particularly in assessing the extent of lymphadenectomy.

  • 3

    Patients with RAPL measurements ≤ 10 mm were classified as having undergone complete vascular ligation (CVL) during surgery.

  • 4

    The study evaluates the association between RAPL and survival outcomes, as well as standard clinicopathological variables.

  • 5

    Findings suggest that RAPL may provide a more objective assessment of surgical quality compared to traditional lymph node harvest metrics.

Original Source(s)

Is computed tomography assessment of residual arterial pedicle length following colorectal cancer surgery a useful marker of surgical quality?

  • by K. Naidu, P. Chapuis, J. Yang, S. Koneru, C. Chan, M. Rickard, K.-S. Ng

  • April 12, 2025

Related Content

Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.

  • by

  • April 28, 2026

  • 5 min
Development and validation of a pre-chemotherapy nomogram integrating systemic immune-inflammation index and prognostic nutritional index to predict severe adjuvant toxicity in colorectal cancer

Multidimensional exploration of the relationship between gut microbiota and colorectal cancer: focus on clinical tumorigenesis and treatment